Continued benefit of nusinersen initiated in the presymptomatic stage of spinal muscular atrophy: 5‐year update of theNURTUREstudy

Post time 2024-4-28 22:17:00

journal：Muscle & Nerve

Authors：Thomas O. Crawford; Kathryn J. Swoboda; Darryl C. De Vivo; Enrico Bertini; Wuh‐Liang Hwu; Richard S. Finkel; Janbernd Kirschner; Nancy L. Kuntz; Aledie Navas Nazario; Julie A. Parsons; Astrid Pechmann; Monique M. Ryan; Russell J. Butterfield; Haluk Topaloglu; Tawfeg Ben‐Omran; Valeria A. Sansone; Yuh‐Jyh Jong; Francy Shu; Cong Zhu; Stephanie Raynaud; Tiffany R. Lago; Angela D. Paradis; Richard Foster; Russell Chin; Zdenek Berger;

Published date：2023-8-

DOI：10.1002/mus.27853

PDF link：https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mus.27853

Article link：http://dx.doi.org/10.1002/mus.27853

Article Source：Wiley。

Remark：

Post time 2024-4-28 22:17:01

: This post has been completed
Completed attachments will be deleted within 24 hours.

[Wiley] Continued benefit of nusinersen initiated in the presymptomatic stage of spinal muscular atrophy: 5‐year update of theNURTUREstudy

Best Answer

Same Category

Latest Reply

Announcement

Enthusiastic users today

[Wiley] Continued benefit of nusinersen initiated in the presymptomatic stage of spinal muscular atrophy: 5‐year update of theNURTUREstudy Copy

Best Answer

Same Category

Latest Reply

Announcement

Enthusiastic users today

[Wiley] Continued benefit of nusinersen initiated in the presymptomatic stage of spinal muscular atrophy: 5‐year update of theNURTUREstudy